Evidence map›Paper›PMID 10330190›Full record

ArticleMolecular and cellular biology1999

Two prion-inducing regions of Ure2p are nonoverlapping.

M L Maddelein, R B Wickner

Abstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 101 citations in OpenAlex.

  1. How Big Is the Yeast Prion Universe?International journal of molecular sciences · 2023
    Review
  2. Article
  3. Article
  4. Amino acid composition predicts prion activity.PLoS computational biology · 2017
    Article
  5. Review
  6. Article
  7. Article
  8. Prions in yeast.Genetics · 2012
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Moonlighting proteins in yeasts.Microbiology and molecular biology reviews : MMBR · 2008
    Review
  17. Article
  18. Primary sequence independence for prion formation.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M L MaddeleinLaboratory of Biochemistry and Genetics, National Institute of Diabetes Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0830, USA.
R B Wickner
National Institutes of Health · US

Funding

PRIONS OF YEASTZ01DK024943 · NIDDK · DIABETES, DIGESTIVE, KIDNEY DISEASES · PI WICKNER, REED B. · 1994 to 2006
–
6 · The paper itself

Abstract

Ure2p of Saccharomyces cerevisiae normally functions in blocking utilization of a poor nitrogen source when a good nitrogen source is available. The non-Mendelian genetic element [URE3] is a prion (infectious protein) form of Ure2p, so that overexpression of Ure2p induces the de novo appearance of infectious [URE3]. Earlier studies defined a prion domain comprising Ure2p residues 1 to 64 and a nitrogen regulation domain included in residues 66 to 354. We find that deletion of individual runs of asparagine within the prion domain reduce prion-inducing activity. Although residues 1 to 64 are sufficient for prion induction, the fragment from residues 1 to 80 is a more efficient inducer of [URE3]. In-frame deletion of a region around residue 224 does not affect nitrogen regulation but does eliminate prion induction by the remainder of Ure2p. Larger deletions removing the region around residue 224 and more of the C-terminal part of Ure2p restore prion-inducing ability. A fragment of Ure2p lacking the original prion domain does not induce [URE3], but surprisingly, further deletion of residues 151 to 157 and 348 to 354 leaves a fragment that can do so. The region from 66 to 80 and the region around residue 224 are both necessary for this second prion-inducing activity. Thus, each of two nonoverlapping parts of Ure2p is sufficient to induce the appearance of the [URE3] prion.

Indexed as

Saccharomyces cerevisiae ProteinsAmyloidosisAnimalsAsparagineBlotting, WesternCrosses, GeneticFungal ProteinsGenetic Complementation TestGlutathione PeroxidaseModels, GeneticPeptide Termination FactorsPhenotypePlasmidsPrionsRepressor ProteinsSaccharomyces cerevisiaeAsparagineFungal ProteinsGlutathione PeroxidasePeptide Termination FactorsPrionsRepressor ProteinsSaccharomyces cerevisiae ProteinsSUP35 protein, S cerevisiaeURE2 protein, S cerevisiae

Identifiers

PMID10330190
PMCPMC104409
OpenAlexW1880600007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.